学科主题临床医学
Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT
Yan, Chen-Hua; Xu, Lan-Ping; Liu, Dai-hong; Chen, Huan; Wang, Yu; Wang, Jing-zhi; Wang, Feng-rong; Han, Wei; Liu, Kai-Yan; Huang, Xiao-Jun
关键词cyclosporine graft-versus-host disease graft-versus-leukemia effect haploidentical hematopoietic stem cell transplantation methotrexate modified donor lymphocyte infusion
刊名CLINICAL TRANSPLANTATION
2015-07-01
DOI10.1111/ctr.12561
29期:7页:594-605
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Surgery ; Transplantation
研究领域[WOS]Surgery ; Transplantation
关键词[WOS]STEM-CELL TRANSPLANTATION ; VERSUS-HOST-DISEASE ; BONE-MARROW-TRANSPLANTATION ; ACUTE MYELOID-LEUKEMIA ; PERIPHERAL-BLOOD LYMPHOCYTES ; HEMATOLOGICAL MALIGNANCIES ; RHEUMATOID-ARTHRITIS ; LEUKOCYTE INFUSIONS ; RISK-FACTORS ; RELAPSE
英文摘要

To compare the impacts of low-dose methotrexate (MTX) with cyclosporine (CSA) on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effect after haploidentical modified donor lymphocyte infusion (DLI). Fifty-five consecutive patients who had relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation (HSCT) and received modified DLI were retrospectively studied. Forty-one patients received CSA and 14 received low-dose MTX after DLI to prevent DLI-associated GVHD. The incidence of acute GVHD and grade 2-4 acute GVHD in MTX group showed a trend toward being higher than in CSA group (61.0% vs. 37.3%, p=0.198 and 61.0% vs. 35.5%, p=0.155). However, no significant difference in the incidence of grade 3-4 acute GVHD between two groups (p=0.982) was observed. Moreover, compared with CSA, patients treated with MTX had lower re-relapse rate (38.1% vs. 80.8%, p=0.029), better disease-free survival (DFS) (51.9% vs. 15.6%, p=0.06), and higher absolute lymphocyte counts at 30, 45, 60, and 90d after modified DLI (p<0.05). This study suggested that after haploidentical modified DLI, low-dose MTX is at least as effective as CSA in the prevention of DLI-associated GVHD and probably allowed stronger GVL effect than CSA. This phenomenon was probably due to a direct antitumor effect and a better reconstitution of lymphocytes after modified DLI induced by low-dose MTX.

语种英语
WOS记录号WOS:000358204300005
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62211
专题医学人文研究院/公共教学部_哲学与社会科学系
北京大学第二临床医学院_血液科
作者单位Peking Univ, Inst Hematol, Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Yan, Chen-Hua,Xu, Lan-Ping,Liu, Dai-hong,et al. Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT[J]. CLINICAL TRANSPLANTATION,2015,29(7):594-605.
APA Yan, Chen-Hua.,Xu, Lan-Ping.,Liu, Dai-hong.,Chen, Huan.,Wang, Yu.,...&Huang, Xiao-Jun.(2015).Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.CLINICAL TRANSPLANTATION,29(7),594-605.
MLA Yan, Chen-Hua,et al."Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT".CLINICAL TRANSPLANTATION 29.7(2015):594-605.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yan, Chen-Hua]的文章
[Xu, Lan-Ping]的文章
[Liu, Dai-hong]的文章
百度学术
百度学术中相似的文章
[Yan, Chen-Hua]的文章
[Xu, Lan-Ping]的文章
[Liu, Dai-hong]的文章
必应学术
必应学术中相似的文章
[Yan, Chen-Hua]的文章
[Xu, Lan-Ping]的文章
[Liu, Dai-hong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。